Thermalin Diabetes LLC

Looking to add to its already substantial diabetes portfolio, Eli Lilly and Company announced on 14 July that it will buy Protomer Technologies , which is working on glucose-sensitive insulins, les

Johnson & Johnson has made a big push with its JLabs life science incubators, with locations in the US biotechnology hubs of San Diego, San Francisco and Boston as well as in Houston, Texas and Toro

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Type 2 diabetes isn’t an obvious spot for any aspiring biotech entrepreneur to invest hard-raised dollars. The highly competitive marketplace is dominated by Sanofi , desperate as $7 billion Lantu